SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations.

SARS-CoV-2 spike protein in complex with Fab 15033-7

The Fab and the spike protein were mixed at 3:1 molar ratio. The total concentration of the proteins was 0.4 mg/mL.

blotting force = 1
blotting time = 2.5 s

Severe acute respiratory syndrome coronavirus 2

Canadian Institutes of Health Research (CIHR)

crystal strucutre of RBD-Fab 15033 complex

crystal strucutre of RBD-Fab 15033-7 complex

spike-3x Fab 15033-7 complex, C3-symmetric

SARS-CoV-2, spike glycoprotein, Fab, VIRAL PROTEIN-Immune System complex, VIRAL PROTEIN